Internal Medicine, Hematology & Oncology · Madison Heights, MI
NPI
1871577544
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
27301 Dequindre Rd, Suite314
Madison Heights, MI, 48071
Phone (248) 399-4400
Groups this clinician bills Medicare through
Medicare paid, 2024
$6.8M
385,662 services
Medicare patients, 2024
898
Average age 76
Drug cost, 2024
$13.2M
5,808 prescriptions
Company payments, 2025
$288
From 7 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jeffrey H Margolis was code J1439 (injection, ferric carboxymaltose, 1 mg), 40,500 times for 35 patients. In total Jeffrey H Margolis billed 385,662 services in 160 codes, and Medicare paid $6.8M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-18.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 40,500 | 35 | $0.87 | $35K |
| J9263 Injection, oxaliplatin, 0.5 mg | Office | 39,400 | 16 | $0.06 | $2,184 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 34,350 | 47 | $0.11 | $3,809 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 26,600 | 21 | $44.61 | $1.2M |
| J9299 Injection, nivolumab, 1 mg | Office | 25,320 | 11 | $24.63 | $624K |
| J0897 Injection, denosumab, 1 mg | Office | 14,880 | 85 | $20.50 | $305K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 6,680 | 16 | $2.31 | $15K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 6,580 | 83 | $0.09 | $595 |
| J1569 Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | Office | 5,862 | 12 | $34.96 | $205K |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 4,820 | 37 | $6.43 | $31K |
| J1449 Injection, eflapegrastim-xnst, 0.1 mg | Office | 4,752 | 29 | $20.59 | $98K |
| Q5123 Injection, rituximab-arrx, biosimilar, (riabni), 10 mg | Office | 4,330 | 17 | $31.68 | $137K |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 4,170 | 70 | $0.71 | $2,971 |
| 85025 Blood Count | Office | 2,865 | 592 | $7.57 | $22K |
| 80047 Clinical Chemistry | Office | 2,633 | 627 | $13.37 | $35K |
By year: 2022 $6.1M for 337,108 services; 2023 $6.5M for 351,336 services; 2024 $6.8M for 385,662 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 2,865 | 592 | $7.57 | $22K |
| 80047 Clinical Chemistry | 2,633 | 627 | $13.37 | $35K |
| 36415 Venipuncture Blood Collection | 20 | 19 | $5.88 | $118 |
Medicare prescription drug claims, 2024
In 2024, the drug Jeffrey H Margolis prescribed most often to Medicare patients was Letrozole, with 729 prescriptions and refills. In total Jeffrey H Margolis wrote 5,808 Medicare prescriptions that cost $13.2M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 729 | 1,774 | 193 | $28K |
| Dexamethasone Generic | 464 | 479 | 124 | $2,402 |
| Prednisone Generic | 290 | 303 | 78 | $1,319 |
| Eliquis Apixaban | 219 | 256 | 48 | $143K |
| Olanzapine Generic | 196 | 196 | 54 | $316 |
| Abiraterone Acetate Generic | 162 | 162 | 23 | $238K |
| Imbruvica Ibrutinib | 144 | 144 | 13 | $2.3M |
| Anastrozole Generic | 137 | 359 | 47 | $5,119 |
| Valacyclovir Valacyclovir Hcl | 133 | 261 | 39 | $5,224 |
| Levothyroxine Sodium Generic | 131 | 283 | 36 | $1,241 |
| Ondansetron Hcl Generic | 131 | 139 | 101 | $1,735 |
| Tamoxifen Citrate Generic | 122 | 312 | 32 | $3,688 |
| Ibrance Palbociclib | 117 | 117 | 12 | $1.8M |
| Omeprazole Generic | 109 | 189 | 44 | $1,146 |
| Ibandronate Sodium Generic | 93 | 188 | 27 | $3,350 |
Brand drugs: 1,226 claims; generic drugs: 4,568 claims; opioid claims: 202.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jeffrey H Margolis $288 ($288 in general payments such as food, travel and fees) from 7 companies. The largest payer was Genmab U.S., Inc. with $132.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.